Related Experiment Video
Updated: Jun 25, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Emerging drugs for acute ischemic stroke
Kenneth M Sicard1, Marc Fisher
1University of Massachusetts Medical School, Worcester, MA 01655, USA.
Abstract:
Stroke is no longer an untreatable condition, and its management is changing rapidly as new developments appear for acute treatments. The objective of this article is to provide a concise introduction to the pathophysiology and existing treatments for stroke, as well as discussing current research goals and interventions under evaluation, along with potential development issues. It will end with the authors' interpretations of the presented material and their opinions about where the field is going, or should go, in the coming years. The material herein is derived from current literature and expert opinion. Overall, the most important findings are that future advances in stroke treatment will probably include combination therapies that will be administered in specialized stroke care units to maximize patient outcome.
Related Concept Videos
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology

